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The primary purpose of the present study was to evaluate the role of lipid and glucose metabolism in vasospastic angina. A group of 93 patients in whom the presence of ischemic heart disease was suggested, were classified into the control (C) group, consisting of 30 patients; the coronary artery disease (CAD) group, consisting of 47 patients; and the vasospastic angina (VSA) group, consisting of 16 patients. Among these three groups, age, total cholesterol (TC), triglyceride (TG), HDL-cholesterol (HDL-C), atherogenic index (AI), apolipoproteins and the prevalence of diabetes mellitus were compared. No age difference was seen among the three groups. The TC was the highest in the CAD group, followed by the VSA and C groups. A significant difference in TC was noted between the C and CAD groups and the C and VSA groups. TG levels were higher in the CAD group than in the C and VSA groups, without a significant difference among the three groups. The AI was significantly higher in the CAD group than in the C and VSA groups. No significant difference was noted in the prevalence of diabetes mellitus among the three groups. Apolipoprotein A-I (apo A-I) levels were higher in the VSA group than in the C and CAD groups, and the difference between the VSA and CAD groups was significant. Apolipoprotein A-II (apo A-II) levels were significantly higher in the VSA group than in the C and CAD groups. Although no significant difference was demonstrated in HDL-C levels in the present study, apo A-II levels were significantly higher in the VSA group, suggesting the presence of lipid metabolism abnormalities, including qualitative abnormalities of HDL in VSA. Serum lipid measurements were performed on blood samples obtained in the early morning after an overnight fast. TC and TG were measured using an autoanalyzer based on an enzymatic method. HDL-C was measured with an enzymatic method after fractionation using dextran magnesium sulfate. The AI was calculated using the formula (TC -HDL-Q/HDL-C. Apolipoprotein was measured using a commercially available kit (Dai-ichi Kagaku) based on a single radial immunodiffusion (SRID) method. A diagnosis of diabetes mellitus was made based on the result of a 75 g GTT according to the WHO criteria.
The results
were analyzed by the unpaired Student's t-test and Chi-squared test, employing p< 0.05 as the level of significance.
All values were expressed as mean ± SEM.
RESULTS
The mean age was not significantly different among the three groups. The influence of age on the presence of atherosclerosis therefore appears to be negligible in this study. Figure 1 shows the comparison of TC, TG, HDL-C, and AI among the three groups. TC levels were 182.4 ± 5.1,238.3 ± 10.1and214.9 ± ll.4
in the C, CAD, and VSA groups, respectively. (The same group order is used for subsequent figures). The value was highest in the CAD group, followed by the VSA and C groups in decreasing order. The value was significantly lower in the C group than in the CAD and VSA groups. No significant difference was noted between the CAD and VSA groups. TGlevels were 182.1 ± 18.7, 210.2 ± 27.9 and 171.8 ± 24.1, respectively. The CAD group tended to have higher values than the C and VSA groups, but no significant difference was noted among the three groups. HDL-C levels were 44.8 ± 2.0, 42.6 ± 1.7 and47.7 ± 3.1, respectively. The CAD group tended to have lower values than the C and VSA groups, but no significant difference was noted amongthe three groups. The AI was 3.3 ± ± 2.1 respectively. The VSA group had a significantly higher value than the C and CAD groups. Apo B, C-II and E levels were not significantly different among the three groups ( Table   2 ).
The prevalence of diabetes mellitus was 16.7%, 23.4% and 12.5% in the three groups, respectively, without significant difference (Fig. 3) . , however, pointed out the role of TG as an independent risk factor in Stockholm prospective study. At the present time, no definite conclusion has been reached regarding this problem. In our results, TG levels tended to be higher in the CAD group than in the C and VSA groups, but no significant difference was noted among the three groups. The relationship between a decrease in HDL-C levels and the occurrence of ischemic heart disease was reported in 1951 (ll). Since the report of Miller et al. (1 2) regarding the significantly decreased levels of HDL-C in patients with ischemic heart disease in 1975, attention has been focused on the significance of evaluated HDL-C levels as a negative risk factor. The Framingham study in 1977 (13) led to the recognition of HDL-C as the most important negative risk factor in ischemic heart disease. Although the anti-atherosclerotic mechanism of HDL has not been completely elucidated, HDL acts as lecithin: cholesterol acyltransferase (LCAT) to esterify free cholesterol in the peripheral tissues and transport it to the liver in a reverse cholesterol transport. This may result in an anti-atherosclerotic action. In the present study, HDL-C levels were not significantly different among the three groups, but the CADgroup tended to have lower values than the C and VSA groups in agreement with the previous reports. AI was calculated using the formula (TC -
DISCUSSION

HDL-C)/HDL-C, TC -HDL-C probably reflects
LDL-C. AI thus reflects both LDL-C and HDL-C, each representing an independent risk factor. AI is thought to be an extremely effective index for coronary atherosclerosis. According to our results, the AI was the highest in the CAD group, followed by the VSA and C groups in decreasing order. The value in the CAD group was significantly higher than in the two other groups, in accordance with previous reports. of control subjects.
In our results, the frequency of diabetes mellitus was the highest in the CAD group at 23.4%, followed by the C group at 16.7% and the VSA group at 12.5%. No significant difference was noted among the three groups. In VSA, the role of diabetes mellitus as a risk factor does not seem to be as important as in CAD. While the mechanism of such a fall in apo A-I and A-II levels and the rise of apo B, and their relationship with the process of coronary atherosclerosis remains unknown, these change are also noted in normolipidemic patients with CAD, and appear to be quite useful in the diagnosis of coronary a thero sclerosis.
According to our results, apo A-I was significantly lower in the CAD group than in the C group, and apo A-II also tended to be lower in comparison with the C group, although the difference was not significant. This is in agreement with the reports by various investigators. Apo B levels showed no significant difference among the three groups. In the VSA group, apo A-I levels tended to be high compared with the C group, although without a significant difference, and apo A-II levels were significantly higher in the VSA group than in the C and CAD groups. Apo A-I and A-II are the main structural proteins of HDL, as previously described.
In the present study, apo A-I and A-II levels tended to be high despite the absence of a significant difference in HDL-C among the three groups. This suggests the presence of lipid metabolism abnormalities, including qualitative abnormalities of HDL, in the VSA group. While the correlation between HDL-C changes and changes of apo A-I and A-II levels was relatively high, an absence of correlation was also reported in some patients with hypertriglyceridemia.
Harano et al. reported the rise of apo A-I and A-II in non insulin dependent diabetes mellitus (NIDDM) despite the tendency of HDL-C to fall. No such dissociation between HDL-C and apo A-I or A-II levels has been reported in patients with VSA. No significant difference was found in apo C-II and E levels among the three groups.
The lipid and glucose metabolism in the three groups were compared based on these results. In attempting to correlate VSA and lipid metabolism, the relationship between coronary vasospasm and coronary atherosclerosis has attracted the most intense attention. 
